Kilian Guse

Kilian Guse began their work experience in 2002 as an Intern in Regulatory Affairs at Bayer. Kilian then moved on to work as an Intern in Business Development at Jennerex Biotherapeutics in 2007. In 2009, they became a Postdoc at Baylor College of Medicine and later transitioned to the role of Senior Researcher at the University of Helsinki in 2011. Kilian then became the CEO of GQ Bio Therapeutics in 2012.

Kilian Guse began their education journey in 1998 at Goethe University Frankfurt, where they pursued a degree in Pharmacy. Kilian completed this program in 2004, earning a PharmD. Afterward, they enrolled in the University of Helsinki in 2005, focusing on Gene Therapy. Kilian dedicated four years to their studies, successfully completing their PhD in Gene Therapy in 2009. Directly following this, they continued their education at Baylor College of Medicine as a postdoctoral student, specializing in Gene Therapy from 2009 to 2011.